In a turn that should surprise exactly no one, the BIRD Group’s Tess Lawrie effortlessly pivots from promoting ivermectin as a cure for COVID-19 to promoting it as a cure for cancer. It’s another example of how single-issue quacks almost inevitably embrace more diverse quackery.
